Stephen Rozzo



E-Posters by Stephen Rozzo
Long-term efficacy and safety of tildrakizumab in patients with psoriasis: Pooled analysis through 3 years of 2 phase 3 trials
Long-term efficacy and safety of tildrakizumab in patients with psoriasis: Pooled analysis through 3 years of 2 phase 3 trials
Diamant Tha├ži, Lars Iversen, Ignasi Pau-Charles, Atsuyuki Igarashi, Mamitaro Ohtsuki, Stephen J Rozzo, Andrew Blauvelt, Kristian Reich